BioElectRx Business Report

April 2022 Issue Contents

Dry eye device therapies staged for a comeback

Olympic Ophthalmics and Oyster Point are pursuing neuromodulation therapies despite Allergan's device exit.

Closed-loop VNS for heart failure has untapped potential

Startup firm Ceryx Medical is using respiratory sinus arrhthmia as a key input in their system.

New indications loom large for bioelectronic medicine

Two industry veterans and an NIH representative offered advice on finding new opportunities.

Bioelectronic medicine investors discuss outlook in NYC

A panel of venture capital professionals discussed the funding outlook at the Bioelectronic Medicine Forum.

Axonics announces commercial launch of F15 SNM system

The new primary cell device complements the company's rechargeable system.

News in brief

News updates from Medtronic and Nyxoah.